Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - Get Free Report)'s share price fell 0.1% during trading on Thursday . The company traded as low as $23.62 and last traded at $23.82. 250,402 shares changed hands during trading, an increase of 21% from the average session volume of 207,787 shares. The stock had previously closed at $23.85.
Analyst Upgrades and Downgrades
Separately, Nomura Securities raised Daiichi Sankyo to a "strong-buy" rating in a report on Friday, June 6th.
Get Our Latest Stock Report on Daiichi Sankyo
Daiichi Sankyo Trading Up 1.1%
The business has a 50 day moving average of $24.71 and a two-hundred day moving average of $25.27. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.85 and a current ratio of 2.53. The firm has a market capitalization of $43.38 billion and a price-to-earnings ratio of 22.23.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.30 EPS for the quarter. The firm had revenue of $3.40 billion during the quarter. Daiichi Sankyo had a return on equity of 17.92% and a net margin of 15.65%. Equities analysts predict that Daiichi Sankyo Co., Ltd. - Sponsored ADR will post 0.73 EPS for the current year.
Daiichi Sankyo Company Profile
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Read More
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
